nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—SLC15A2—multiple sclerosis	0.421	0.656	CbGaD
Perindopril—BCHE—multiple sclerosis	0.221	0.344	CbGaD
Perindopril—BCHE—Triamcinolone—multiple sclerosis	0.0855	0.409	CbGbCtD
Perindopril—ABCB1—Methylprednisolone—multiple sclerosis	0.0286	0.137	CbGbCtD
Perindopril—ABCB1—Mitoxantrone—multiple sclerosis	0.0209	0.1	CbGbCtD
Perindopril—ABCB1—Betamethasone—multiple sclerosis	0.0186	0.0891	CbGbCtD
Perindopril—ABCB1—Prednisolone—multiple sclerosis	0.0184	0.0879	CbGbCtD
Perindopril—ABCB1—Prednisone—multiple sclerosis	0.0173	0.083	CbGbCtD
Perindopril—ABCB1—Dexamethasone—multiple sclerosis	0.0108	0.0518	CbGbCtD
Perindopril—ABCB1—Methotrexate—multiple sclerosis	0.0087	0.0417	CbGbCtD
Perindopril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00238	0.393	CbGpPWpGaD
Perindopril—ACE—peripheral nervous system—multiple sclerosis	0.000934	0.177	CbGeAlD
Perindopril—Spirapril—SLC15A2—multiple sclerosis	0.000919	0.169	CrCbGaD
Perindopril—Moexipril—SLC15A2—multiple sclerosis	0.000881	0.162	CrCbGaD
Perindopril—Cilazapril—SLC15A2—multiple sclerosis	0.000819	0.151	CrCbGaD
Perindopril—Quinapril—SLC15A2—multiple sclerosis	0.000819	0.151	CrCbGaD
Perindopril—Ramipril—SLC15A2—multiple sclerosis	0.000793	0.146	CrCbGaD
Perindopril—Trandolapril—SLC15A2—multiple sclerosis	0.000793	0.146	CrCbGaD
Perindopril—ACE—nerve—multiple sclerosis	0.000728	0.138	CbGeAlD
Perindopril—Ramipril—BCHE—multiple sclerosis	0.000416	0.0765	CrCbGaD
Perindopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.00032	0.0529	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.00027	0.0446	CbGpPWpGaD
Perindopril—SLC15A2—retina—multiple sclerosis	0.000263	0.0498	CbGeAlD
Perindopril—BCHE—brainstem—multiple sclerosis	0.000231	0.0437	CbGeAlD
Perindopril—ACE—spinal cord—multiple sclerosis	0.000194	0.0368	CbGeAlD
Perindopril—SLC15A2—medulla oblongata—multiple sclerosis	0.00019	0.036	CbGeAlD
Perindopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000189	0.0312	CbGpPWpGaD
Perindopril—SLC15A2—midbrain—multiple sclerosis	0.000174	0.0329	CbGeAlD
Perindopril—SLC15A2—spinal cord—multiple sclerosis	0.000169	0.0321	CbGeAlD
Perindopril—ACE—nervous system—multiple sclerosis	0.000164	0.031	CbGeAlD
Perindopril—BCHE—medulla oblongata—multiple sclerosis	0.000161	0.0305	CbGeAlD
Perindopril—ACE—central nervous system—multiple sclerosis	0.000158	0.0299	CbGeAlD
Perindopril—ACE—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.000156	0.0257	CbGpPWpGaD
Perindopril—BCHE—midbrain—multiple sclerosis	0.000147	0.0279	CbGeAlD
Perindopril—ACE—Peptide hormone metabolism—BCHE—multiple sclerosis	0.000144	0.0238	CbGpPWpGaD
Perindopril—BCHE—spinal cord—multiple sclerosis	0.000144	0.0272	CbGeAlD
Perindopril—SLC15A2—nervous system—multiple sclerosis	0.000143	0.027	CbGeAlD
Perindopril—SLC15A2—central nervous system—multiple sclerosis	0.000137	0.026	CbGeAlD
Perindopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000135	0.0223	CbGpPWpGaD
Perindopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000135	0.0223	CbGpPWpGaD
Perindopril—SLC15A2—cerebellum—multiple sclerosis	0.000134	0.0254	CbGeAlD
Perindopril—ACE—brain—multiple sclerosis	0.000125	0.0237	CbGeAlD
Perindopril—BCHE—nervous system—multiple sclerosis	0.000121	0.0229	CbGeAlD
Perindopril—BCHE—central nervous system—multiple sclerosis	0.000116	0.0221	CbGeAlD
Perindopril—BCHE—cerebellum—multiple sclerosis	0.000114	0.0216	CbGeAlD
Perindopril—SLC15A2—brain—multiple sclerosis	0.000109	0.0207	CbGeAlD
Perindopril—BCHE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.000108	0.0179	CbGpPWpGaD
Perindopril—ABCB1—retina—multiple sclerosis	0.000106	0.0201	CbGeAlD
Perindopril—BCHE—brain—multiple sclerosis	9.25e-05	0.0175	CbGeAlD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	8.43e-05	0.0139	CbGpPWpGaD
Perindopril—Sweating—Methotrexate—multiple sclerosis	8.42e-05	0.000638	CcSEcCtD
Perindopril—Haematuria—Methotrexate—multiple sclerosis	8.38e-05	0.000634	CcSEcCtD
Perindopril—Shock—Triamcinolone—multiple sclerosis	8.35e-05	0.000632	CcSEcCtD
Perindopril—Insomnia—Prednisolone—multiple sclerosis	8.34e-05	0.000632	CcSEcCtD
Perindopril—Alopecia—Prednisone—multiple sclerosis	8.34e-05	0.000632	CcSEcCtD
Perindopril—Shock—Methylprednisolone—multiple sclerosis	8.33e-05	0.000631	CcSEcCtD
Perindopril—Hepatobiliary disease—Methotrexate—multiple sclerosis	8.31e-05	0.000629	CcSEcCtD
Perindopril—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.3e-05	0.000629	CcSEcCtD
Perindopril—Loss of consciousness—Betamethasone—multiple sclerosis	8.29e-05	0.000628	CcSEcCtD
Perindopril—Loss of consciousness—Dexamethasone—multiple sclerosis	8.29e-05	0.000628	CcSEcCtD
Perindopril—Epistaxis—Methotrexate—multiple sclerosis	8.29e-05	0.000628	CcSEcCtD
Perindopril—Paraesthesia—Prednisolone—multiple sclerosis	8.28e-05	0.000627	CcSEcCtD
Perindopril—Tachycardia—Triamcinolone—multiple sclerosis	8.28e-05	0.000627	CcSEcCtD
Perindopril—Mental disorder—Prednisone—multiple sclerosis	8.27e-05	0.000626	CcSEcCtD
Perindopril—Nausea—Azathioprine—multiple sclerosis	8.26e-05	0.000626	CcSEcCtD
Perindopril—Tachycardia—Methylprednisolone—multiple sclerosis	8.26e-05	0.000626	CcSEcCtD
Perindopril—Skin disorder—Methylprednisolone—multiple sclerosis	8.22e-05	0.000623	CcSEcCtD
Perindopril—Malnutrition—Prednisone—multiple sclerosis	8.21e-05	0.000622	CcSEcCtD
Perindopril—Erythema—Prednisone—multiple sclerosis	8.21e-05	0.000622	CcSEcCtD
Perindopril—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.2e-05	0.000621	CcSEcCtD
Perindopril—Agranulocytosis—Methotrexate—multiple sclerosis	8.2e-05	0.000621	CcSEcCtD
Perindopril—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.18e-05	0.00062	CcSEcCtD
Perindopril—Hypertension—Betamethasone—multiple sclerosis	8.14e-05	0.000617	CcSEcCtD
Perindopril—Hypertension—Dexamethasone—multiple sclerosis	8.14e-05	0.000617	CcSEcCtD
Perindopril—Asthenia—Mitoxantrone—multiple sclerosis	8.07e-05	0.000611	CcSEcCtD
Perindopril—Myalgia—Dexamethasone—multiple sclerosis	8.03e-05	0.000608	CcSEcCtD
Perindopril—Myalgia—Betamethasone—multiple sclerosis	8.03e-05	0.000608	CcSEcCtD
Perindopril—Anxiety—Betamethasone—multiple sclerosis	8e-05	0.000606	CcSEcCtD
Perindopril—Anxiety—Dexamethasone—multiple sclerosis	8e-05	0.000606	CcSEcCtD
Perindopril—BCHE—Neuronal System—KCNA3—multiple sclerosis	7.96e-05	0.0132	CbGpPWpGaD
Perindopril—Discomfort—Betamethasone—multiple sclerosis	7.93e-05	0.000601	CcSEcCtD
Perindopril—Discomfort—Dexamethasone—multiple sclerosis	7.93e-05	0.000601	CcSEcCtD
Perindopril—Haemoglobin—Methotrexate—multiple sclerosis	7.93e-05	0.0006	CcSEcCtD
Perindopril—Hypotension—Methylprednisolone—multiple sclerosis	7.91e-05	0.000599	CcSEcCtD
Perindopril—Pain—Prednisolone—multiple sclerosis	7.89e-05	0.000598	CcSEcCtD
Perindopril—Haemorrhage—Methotrexate—multiple sclerosis	7.89e-05	0.000597	CcSEcCtD
Perindopril—Hepatitis—Methotrexate—multiple sclerosis	7.89e-05	0.000597	CcSEcCtD
Perindopril—Pharyngitis—Methotrexate—multiple sclerosis	7.83e-05	0.000593	CcSEcCtD
Perindopril—Urinary tract disorder—Methotrexate—multiple sclerosis	7.79e-05	0.00059	CcSEcCtD
Perindopril—Urethral disorder—Methotrexate—multiple sclerosis	7.73e-05	0.000586	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.73e-05	0.000585	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.71e-05	0.000584	CcSEcCtD
Perindopril—Oedema—Betamethasone—multiple sclerosis	7.7e-05	0.000583	CcSEcCtD
Perindopril—Oedema—Dexamethasone—multiple sclerosis	7.7e-05	0.000583	CcSEcCtD
Perindopril—Anaphylactic shock—Betamethasone—multiple sclerosis	7.7e-05	0.000583	CcSEcCtD
Perindopril—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.7e-05	0.000583	CcSEcCtD
Perindopril—Diarrhoea—Mitoxantrone—multiple sclerosis	7.69e-05	0.000583	CcSEcCtD
Perindopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	7.68e-05	0.0127	CbGpPWpGaD
Perindopril—Insomnia—Triamcinolone—multiple sclerosis	7.67e-05	0.000581	CcSEcCtD
Perindopril—ABCB1—medulla oblongata—multiple sclerosis	7.67e-05	0.0145	CbGeAlD
Perindopril—Insomnia—Methylprednisolone—multiple sclerosis	7.66e-05	0.00058	CcSEcCtD
Perindopril—Ill-defined disorder—Prednisone—multiple sclerosis	7.62e-05	0.000577	CcSEcCtD
Perindopril—Paraesthesia—Triamcinolone—multiple sclerosis	7.62e-05	0.000577	CcSEcCtD
Perindopril—Feeling abnormal—Prednisolone—multiple sclerosis	7.6e-05	0.000576	CcSEcCtD
Perindopril—Paraesthesia—Methylprednisolone—multiple sclerosis	7.6e-05	0.000576	CcSEcCtD
Perindopril—Visual impairment—Methotrexate—multiple sclerosis	7.6e-05	0.000576	CcSEcCtD
Perindopril—Anaemia—Prednisone—multiple sclerosis	7.59e-05	0.000575	CcSEcCtD
Perindopril—Shock—Dexamethasone—multiple sclerosis	7.57e-05	0.000574	CcSEcCtD
Perindopril—Shock—Betamethasone—multiple sclerosis	7.57e-05	0.000574	CcSEcCtD
Perindopril—Dyspnoea—Triamcinolone—multiple sclerosis	7.56e-05	0.000573	CcSEcCtD
Perindopril—Nervous system disorder—Dexamethasone—multiple sclerosis	7.55e-05	0.000572	CcSEcCtD
Perindopril—Nervous system disorder—Betamethasone—multiple sclerosis	7.55e-05	0.000572	CcSEcCtD
Perindopril—Agitation—Prednisone—multiple sclerosis	7.55e-05	0.000572	CcSEcCtD
Perindopril—Thrombocytopenia—Betamethasone—multiple sclerosis	7.54e-05	0.000571	CcSEcCtD
Perindopril—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.54e-05	0.000571	CcSEcCtD
Perindopril—Tachycardia—Dexamethasone—multiple sclerosis	7.51e-05	0.000569	CcSEcCtD
Perindopril—Tachycardia—Betamethasone—multiple sclerosis	7.51e-05	0.000569	CcSEcCtD
Perindopril—Angioedema—Prednisone—multiple sclerosis	7.51e-05	0.000568	CcSEcCtD
Perindopril—Dyspepsia—Triamcinolone—multiple sclerosis	7.47e-05	0.000566	CcSEcCtD
Perindopril—Erythema multiforme—Methotrexate—multiple sclerosis	7.46e-05	0.000565	CcSEcCtD
Perindopril—Dyspepsia—Methylprednisolone—multiple sclerosis	7.45e-05	0.000564	CcSEcCtD
Perindopril—ACE—Peptide hormone metabolism—POMC—multiple sclerosis	7.44e-05	0.0123	CbGpPWpGaD
Perindopril—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.44e-05	0.000564	CcSEcCtD
Perindopril—Hyperhidrosis—Betamethasone—multiple sclerosis	7.44e-05	0.000564	CcSEcCtD
Perindopril—Malaise—Prednisone—multiple sclerosis	7.41e-05	0.000561	CcSEcCtD
Perindopril—Vertigo—Prednisone—multiple sclerosis	7.38e-05	0.000559	CcSEcCtD
Perindopril—Eye disorder—Methotrexate—multiple sclerosis	7.37e-05	0.000558	CcSEcCtD
Perindopril—Syncope—Prednisone—multiple sclerosis	7.37e-05	0.000558	CcSEcCtD
Perindopril—Tinnitus—Methotrexate—multiple sclerosis	7.35e-05	0.000557	CcSEcCtD
Perindopril—Anorexia—Dexamethasone—multiple sclerosis	7.34e-05	0.000556	CcSEcCtD
Perindopril—Anorexia—Betamethasone—multiple sclerosis	7.34e-05	0.000556	CcSEcCtD
Perindopril—Urticaria—Prednisolone—multiple sclerosis	7.33e-05	0.000555	CcSEcCtD
Perindopril—Cardiac disorder—Methotrexate—multiple sclerosis	7.32e-05	0.000554	CcSEcCtD
Perindopril—Fatigue—Triamcinolone—multiple sclerosis	7.31e-05	0.000554	CcSEcCtD
Perindopril—Fatigue—Methylprednisolone—multiple sclerosis	7.3e-05	0.000553	CcSEcCtD
Perindopril—Pain—Triamcinolone—multiple sclerosis	7.25e-05	0.00055	CcSEcCtD
Perindopril—Loss of consciousness—Prednisone—multiple sclerosis	7.22e-05	0.000547	CcSEcCtD
Perindopril—Hypotension—Betamethasone—multiple sclerosis	7.19e-05	0.000545	CcSEcCtD
Perindopril—Hypotension—Dexamethasone—multiple sclerosis	7.19e-05	0.000545	CcSEcCtD
Perindopril—Angiopathy—Methotrexate—multiple sclerosis	7.15e-05	0.000542	CcSEcCtD
Perindopril—Vomiting—Mitoxantrone—multiple sclerosis	7.15e-05	0.000542	CcSEcCtD
Perindopril—Mediastinal disorder—Methotrexate—multiple sclerosis	7.11e-05	0.000538	CcSEcCtD
Perindopril—Hypertension—Prednisone—multiple sclerosis	7.09e-05	0.000537	CcSEcCtD
Perindopril—Rash—Mitoxantrone—multiple sclerosis	7.09e-05	0.000537	CcSEcCtD
Perindopril—Dermatitis—Mitoxantrone—multiple sclerosis	7.08e-05	0.000537	CcSEcCtD
Perindopril—Chills—Methotrexate—multiple sclerosis	7.08e-05	0.000536	CcSEcCtD
Perindopril—Headache—Mitoxantrone—multiple sclerosis	7.04e-05	0.000534	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.01e-05	0.000531	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.01e-05	0.000531	CcSEcCtD
Perindopril—ABCB1—midbrain—multiple sclerosis	7.01e-05	0.0133	CbGeAlD
Perindopril—Arthralgia—Prednisone—multiple sclerosis	6.99e-05	0.00053	CcSEcCtD
Perindopril—Myalgia—Prednisone—multiple sclerosis	6.99e-05	0.00053	CcSEcCtD
Perindopril—Feeling abnormal—Triamcinolone—multiple sclerosis	6.99e-05	0.00053	CcSEcCtD
Perindopril—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.98e-05	0.000528	CcSEcCtD
Perindopril—Anxiety—Prednisone—multiple sclerosis	6.97e-05	0.000528	CcSEcCtD
Perindopril—Alopecia—Methotrexate—multiple sclerosis	6.97e-05	0.000528	CcSEcCtD
Perindopril—Insomnia—Dexamethasone—multiple sclerosis	6.96e-05	0.000527	CcSEcCtD
Perindopril—Insomnia—Betamethasone—multiple sclerosis	6.96e-05	0.000527	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.94e-05	0.000526	CcSEcCtD
Perindopril—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.92e-05	0.000524	CcSEcCtD
Perindopril—Paraesthesia—Dexamethasone—multiple sclerosis	6.91e-05	0.000524	CcSEcCtD
Perindopril—Paraesthesia—Betamethasone—multiple sclerosis	6.91e-05	0.000524	CcSEcCtD
Perindopril—Discomfort—Prednisone—multiple sclerosis	6.91e-05	0.000523	CcSEcCtD
Perindopril—Mental disorder—Methotrexate—multiple sclerosis	6.91e-05	0.000523	CcSEcCtD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	6.88e-05	0.0114	CbGpPWpGaD
Perindopril—Malnutrition—Methotrexate—multiple sclerosis	6.86e-05	0.00052	CcSEcCtD
Perindopril—Erythema—Methotrexate—multiple sclerosis	6.86e-05	0.00052	CcSEcCtD
Perindopril—ABCB1—spinal cord—multiple sclerosis	6.84e-05	0.013	CbGeAlD
Perindopril—Dyspepsia—Dexamethasone—multiple sclerosis	6.78e-05	0.000513	CcSEcCtD
Perindopril—Dyspepsia—Betamethasone—multiple sclerosis	6.78e-05	0.000513	CcSEcCtD
Perindopril—Urticaria—Triamcinolone—multiple sclerosis	6.74e-05	0.00051	CcSEcCtD
Perindopril—Urticaria—Methylprednisolone—multiple sclerosis	6.72e-05	0.000509	CcSEcCtD
Perindopril—Dysgeusia—Methotrexate—multiple sclerosis	6.72e-05	0.000509	CcSEcCtD
Perindopril—Body temperature increased—Triamcinolone—multiple sclerosis	6.71e-05	0.000508	CcSEcCtD
Perindopril—Oedema—Prednisone—multiple sclerosis	6.7e-05	0.000508	CcSEcCtD
Perindopril—Anaphylactic shock—Prednisone—multiple sclerosis	6.7e-05	0.000508	CcSEcCtD
Perindopril—Abdominal pain—Methylprednisolone—multiple sclerosis	6.69e-05	0.000507	CcSEcCtD
Perindopril—Decreased appetite—Dexamethasone—multiple sclerosis	6.69e-05	0.000507	CcSEcCtD
Perindopril—Decreased appetite—Betamethasone—multiple sclerosis	6.69e-05	0.000507	CcSEcCtD
Perindopril—Nausea—Mitoxantrone—multiple sclerosis	6.68e-05	0.000506	CcSEcCtD
Perindopril—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.65e-05	0.000503	CcSEcCtD
Perindopril—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.65e-05	0.000503	CcSEcCtD
Perindopril—Back pain—Methotrexate—multiple sclerosis	6.64e-05	0.000503	CcSEcCtD
Perindopril—Fatigue—Dexamethasone—multiple sclerosis	6.64e-05	0.000503	CcSEcCtD
Perindopril—Fatigue—Betamethasone—multiple sclerosis	6.64e-05	0.000503	CcSEcCtD
Perindopril—Shock—Prednisone—multiple sclerosis	6.6e-05	0.0005	CcSEcCtD
Perindopril—Pain—Dexamethasone—multiple sclerosis	6.58e-05	0.000499	CcSEcCtD
Perindopril—Pain—Betamethasone—multiple sclerosis	6.58e-05	0.000499	CcSEcCtD
Perindopril—Nervous system disorder—Prednisone—multiple sclerosis	6.57e-05	0.000498	CcSEcCtD
Perindopril—Tachycardia—Prednisone—multiple sclerosis	6.54e-05	0.000496	CcSEcCtD
Perindopril—Skin disorder—Prednisone—multiple sclerosis	6.51e-05	0.000493	CcSEcCtD
Perindopril—Hyperhidrosis—Prednisone—multiple sclerosis	6.48e-05	0.000491	CcSEcCtD
Perindopril—Anorexia—Prednisone—multiple sclerosis	6.39e-05	0.000484	CcSEcCtD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	6.39e-05	0.0106	CbGpPWpGaD
Perindopril—Ill-defined disorder—Methotrexate—multiple sclerosis	6.37e-05	0.000482	CcSEcCtD
Perindopril—Anaemia—Methotrexate—multiple sclerosis	6.34e-05	0.000481	CcSEcCtD
Perindopril—Feeling abnormal—Betamethasone—multiple sclerosis	6.34e-05	0.00048	CcSEcCtD
Perindopril—Feeling abnormal—Dexamethasone—multiple sclerosis	6.34e-05	0.00048	CcSEcCtD
Perindopril—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.29e-05	0.000477	CcSEcCtD
Perindopril—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.29e-05	0.000477	CcSEcCtD
Perindopril—Malaise—Methotrexate—multiple sclerosis	6.19e-05	0.000469	CcSEcCtD
Perindopril—Vertigo—Methotrexate—multiple sclerosis	6.17e-05	0.000467	CcSEcCtD
Perindopril—Leukopenia—Methotrexate—multiple sclerosis	6.14e-05	0.000465	CcSEcCtD
Perindopril—Urticaria—Betamethasone—multiple sclerosis	6.12e-05	0.000463	CcSEcCtD
Perindopril—Urticaria—Dexamethasone—multiple sclerosis	6.12e-05	0.000463	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.11e-05	0.000463	CcSEcCtD
Perindopril—Dizziness—Prednisolone—multiple sclerosis	6.1e-05	0.000462	CcSEcCtD
Perindopril—Asthenia—Triamcinolone—multiple sclerosis	6.09e-05	0.000461	CcSEcCtD
Perindopril—Abdominal pain—Betamethasone—multiple sclerosis	6.09e-05	0.000461	CcSEcCtD
Perindopril—Body temperature increased—Betamethasone—multiple sclerosis	6.09e-05	0.000461	CcSEcCtD
Perindopril—Abdominal pain—Dexamethasone—multiple sclerosis	6.09e-05	0.000461	CcSEcCtD
Perindopril—Body temperature increased—Dexamethasone—multiple sclerosis	6.09e-05	0.000461	CcSEcCtD
Perindopril—Asthenia—Methylprednisolone—multiple sclerosis	6.07e-05	0.00046	CcSEcCtD
Perindopril—Insomnia—Prednisone—multiple sclerosis	6.06e-05	0.000459	CcSEcCtD
Perindopril—Paraesthesia—Prednisone—multiple sclerosis	6.02e-05	0.000456	CcSEcCtD
Perindopril—Pruritus—Triamcinolone—multiple sclerosis	6e-05	0.000455	CcSEcCtD
Perindopril—Cough—Methotrexate—multiple sclerosis	5.99e-05	0.000454	CcSEcCtD
Perindopril—Pruritus—Methylprednisolone—multiple sclerosis	5.99e-05	0.000454	CcSEcCtD
Perindopril—Dyspepsia—Prednisone—multiple sclerosis	5.9e-05	0.000447	CcSEcCtD
Perindopril—Chest pain—Methotrexate—multiple sclerosis	5.84e-05	0.000443	CcSEcCtD
Perindopril—Arthralgia—Methotrexate—multiple sclerosis	5.84e-05	0.000443	CcSEcCtD
Perindopril—Myalgia—Methotrexate—multiple sclerosis	5.84e-05	0.000443	CcSEcCtD
Perindopril—ABCB1—Allograft Rejection—C4A—multiple sclerosis	5.84e-05	0.00965	CbGpPWpGaD
Perindopril—Decreased appetite—Prednisone—multiple sclerosis	5.83e-05	0.000441	CcSEcCtD
Perindopril—Rash—Prednisolone—multiple sclerosis	5.82e-05	0.000441	CcSEcCtD
Perindopril—Dermatitis—Prednisolone—multiple sclerosis	5.81e-05	0.00044	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.8e-05	0.00044	CcSEcCtD
Perindopril—Diarrhoea—Methylprednisolone—multiple sclerosis	5.79e-05	0.000439	CcSEcCtD
Perindopril—Fatigue—Prednisone—multiple sclerosis	5.78e-05	0.000438	CcSEcCtD
Perindopril—Headache—Prednisolone—multiple sclerosis	5.78e-05	0.000438	CcSEcCtD
Perindopril—Discomfort—Methotrexate—multiple sclerosis	5.77e-05	0.000437	CcSEcCtD
Perindopril—ABCB1—nervous system—multiple sclerosis	5.76e-05	0.0109	CbGeAlD
Perindopril—Constipation—Prednisone—multiple sclerosis	5.73e-05	0.000434	CcSEcCtD
Perindopril—Confusional state—Methotrexate—multiple sclerosis	5.65e-05	0.000428	CcSEcCtD
Perindopril—Dizziness—Triamcinolone—multiple sclerosis	5.61e-05	0.000425	CcSEcCtD
Perindopril—Anaphylactic shock—Methotrexate—multiple sclerosis	5.6e-05	0.000424	CcSEcCtD
Perindopril—Dizziness—Methylprednisolone—multiple sclerosis	5.6e-05	0.000424	CcSEcCtD
Perindopril—ABCB1—central nervous system—multiple sclerosis	5.55e-05	0.0105	CbGeAlD
Perindopril—Feeling abnormal—Prednisone—multiple sclerosis	5.52e-05	0.000418	CcSEcCtD
Perindopril—Asthenia—Dexamethasone—multiple sclerosis	5.52e-05	0.000418	CcSEcCtD
Perindopril—Asthenia—Betamethasone—multiple sclerosis	5.52e-05	0.000418	CcSEcCtD
Perindopril—Nervous system disorder—Methotrexate—multiple sclerosis	5.49e-05	0.000416	CcSEcCtD
Perindopril—Thrombocytopenia—Methotrexate—multiple sclerosis	5.49e-05	0.000415	CcSEcCtD
Perindopril—Gastrointestinal pain—Prednisone—multiple sclerosis	5.48e-05	0.000415	CcSEcCtD
Perindopril—Nausea—Prednisolone—multiple sclerosis	5.48e-05	0.000415	CcSEcCtD
Perindopril—Pruritus—Betamethasone—multiple sclerosis	5.45e-05	0.000413	CcSEcCtD
Perindopril—Pruritus—Dexamethasone—multiple sclerosis	5.45e-05	0.000413	CcSEcCtD
Perindopril—Skin disorder—Methotrexate—multiple sclerosis	5.44e-05	0.000412	CcSEcCtD
Perindopril—ABCB1—cerebellum—multiple sclerosis	5.42e-05	0.0103	CbGeAlD
Perindopril—Hyperhidrosis—Methotrexate—multiple sclerosis	5.42e-05	0.00041	CcSEcCtD
Perindopril—Vomiting—Triamcinolone—multiple sclerosis	5.39e-05	0.000409	CcSEcCtD
Perindopril—Vomiting—Methylprednisolone—multiple sclerosis	5.38e-05	0.000408	CcSEcCtD
Perindopril—Rash—Triamcinolone—multiple sclerosis	5.35e-05	0.000405	CcSEcCtD
Perindopril—Dermatitis—Triamcinolone—multiple sclerosis	5.34e-05	0.000405	CcSEcCtD
Perindopril—Anorexia—Methotrexate—multiple sclerosis	5.34e-05	0.000405	CcSEcCtD
Perindopril—Rash—Methylprednisolone—multiple sclerosis	5.34e-05	0.000404	CcSEcCtD
Perindopril—Dermatitis—Methylprednisolone—multiple sclerosis	5.33e-05	0.000404	CcSEcCtD
Perindopril—Urticaria—Prednisone—multiple sclerosis	5.33e-05	0.000403	CcSEcCtD
Perindopril—Headache—Triamcinolone—multiple sclerosis	5.31e-05	0.000403	CcSEcCtD
Perindopril—Headache—Methylprednisolone—multiple sclerosis	5.3e-05	0.000402	CcSEcCtD
Perindopril—Body temperature increased—Prednisone—multiple sclerosis	5.3e-05	0.000401	CcSEcCtD
Perindopril—Abdominal pain—Prednisone—multiple sclerosis	5.3e-05	0.000401	CcSEcCtD
Perindopril—Diarrhoea—Betamethasone—multiple sclerosis	5.27e-05	0.000399	CcSEcCtD
Perindopril—Diarrhoea—Dexamethasone—multiple sclerosis	5.27e-05	0.000399	CcSEcCtD
Perindopril—Hypotension—Methotrexate—multiple sclerosis	5.24e-05	0.000397	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.1e-05	0.000387	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—SLC30A7—multiple sclerosis	5.09e-05	0.00841	CbGpPWpGaD
Perindopril—Dizziness—Betamethasone—multiple sclerosis	5.09e-05	0.000386	CcSEcCtD
Perindopril—Dizziness—Dexamethasone—multiple sclerosis	5.09e-05	0.000386	CcSEcCtD
Perindopril—Insomnia—Methotrexate—multiple sclerosis	5.07e-05	0.000384	CcSEcCtD
Perindopril—Nausea—Triamcinolone—multiple sclerosis	5.04e-05	0.000382	CcSEcCtD
Perindopril—Paraesthesia—Methotrexate—multiple sclerosis	5.03e-05	0.000381	CcSEcCtD
Perindopril—Nausea—Methylprednisolone—multiple sclerosis	5.03e-05	0.000381	CcSEcCtD
Perindopril—Dyspnoea—Methotrexate—multiple sclerosis	4.99e-05	0.000378	CcSEcCtD
Perindopril—Somnolence—Methotrexate—multiple sclerosis	4.98e-05	0.000377	CcSEcCtD
Perindopril—Dyspepsia—Methotrexate—multiple sclerosis	4.93e-05	0.000374	CcSEcCtD
Perindopril—Vomiting—Dexamethasone—multiple sclerosis	4.89e-05	0.000371	CcSEcCtD
Perindopril—Vomiting—Betamethasone—multiple sclerosis	4.89e-05	0.000371	CcSEcCtD
Perindopril—Decreased appetite—Methotrexate—multiple sclerosis	4.87e-05	0.000369	CcSEcCtD
Perindopril—Rash—Betamethasone—multiple sclerosis	4.85e-05	0.000368	CcSEcCtD
Perindopril—Rash—Dexamethasone—multiple sclerosis	4.85e-05	0.000368	CcSEcCtD
Perindopril—Dermatitis—Betamethasone—multiple sclerosis	4.85e-05	0.000367	CcSEcCtD
Perindopril—Dermatitis—Dexamethasone—multiple sclerosis	4.85e-05	0.000367	CcSEcCtD
Perindopril—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.84e-05	0.000366	CcSEcCtD
Perindopril—Fatigue—Methotrexate—multiple sclerosis	4.83e-05	0.000366	CcSEcCtD
Perindopril—Headache—Dexamethasone—multiple sclerosis	4.82e-05	0.000365	CcSEcCtD
Perindopril—Headache—Betamethasone—multiple sclerosis	4.82e-05	0.000365	CcSEcCtD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.81e-05	0.00794	CbGpPWpGaD
Perindopril—Asthenia—Prednisone—multiple sclerosis	4.81e-05	0.000364	CcSEcCtD
Perindopril—Pain—Methotrexate—multiple sclerosis	4.79e-05	0.000363	CcSEcCtD
Perindopril—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	4.76e-05	0.00787	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	4.76e-05	0.00787	CbGpPWpGaD
Perindopril—Pruritus—Prednisone—multiple sclerosis	4.74e-05	0.000359	CcSEcCtD
Perindopril—Feeling abnormal—Methotrexate—multiple sclerosis	4.62e-05	0.00035	CcSEcCtD
Perindopril—Diarrhoea—Prednisone—multiple sclerosis	4.59e-05	0.000347	CcSEcCtD
Perindopril—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.58e-05	0.000347	CcSEcCtD
Perindopril—Nausea—Betamethasone—multiple sclerosis	4.57e-05	0.000346	CcSEcCtD
Perindopril—Nausea—Dexamethasone—multiple sclerosis	4.57e-05	0.000346	CcSEcCtD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.46e-05	0.00737	CbGpPWpGaD
Perindopril—Urticaria—Methotrexate—multiple sclerosis	4.45e-05	0.000337	CcSEcCtD
Perindopril—Dizziness—Prednisone—multiple sclerosis	4.43e-05	0.000336	CcSEcCtD
Perindopril—Body temperature increased—Methotrexate—multiple sclerosis	4.43e-05	0.000335	CcSEcCtD
Perindopril—Abdominal pain—Methotrexate—multiple sclerosis	4.43e-05	0.000335	CcSEcCtD
Perindopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.41e-05	0.00729	CbGpPWpGaD
Perindopril—ABCB1—brain—multiple sclerosis	4.41e-05	0.00834	CbGeAlD
Perindopril—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	4.33e-05	0.00716	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.28e-05	0.00707	CbGpPWpGaD
Perindopril—Vomiting—Prednisone—multiple sclerosis	4.26e-05	0.000323	CcSEcCtD
Perindopril—Rash—Prednisone—multiple sclerosis	4.23e-05	0.00032	CcSEcCtD
Perindopril—Dermatitis—Prednisone—multiple sclerosis	4.22e-05	0.00032	CcSEcCtD
Perindopril—Headache—Prednisone—multiple sclerosis	4.2e-05	0.000318	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—PABPC1—multiple sclerosis	4.12e-05	0.0068	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	4.09e-05	0.00675	CbGpPWpGaD
Perindopril—Asthenia—Methotrexate—multiple sclerosis	4.02e-05	0.000304	CcSEcCtD
Perindopril—Nausea—Prednisone—multiple sclerosis	3.98e-05	0.000302	CcSEcCtD
Perindopril—Pruritus—Methotrexate—multiple sclerosis	3.96e-05	0.0003	CcSEcCtD
Perindopril—Diarrhoea—Methotrexate—multiple sclerosis	3.83e-05	0.00029	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—RPL5—multiple sclerosis	3.72e-05	0.00614	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	3.71e-05	0.00613	CbGpPWpGaD
Perindopril—Dizziness—Methotrexate—multiple sclerosis	3.7e-05	0.000281	CcSEcCtD
Perindopril—Vomiting—Methotrexate—multiple sclerosis	3.56e-05	0.00027	CcSEcCtD
Perindopril—Rash—Methotrexate—multiple sclerosis	3.53e-05	0.000268	CcSEcCtD
Perindopril—Dermatitis—Methotrexate—multiple sclerosis	3.53e-05	0.000267	CcSEcCtD
Perindopril—Headache—Methotrexate—multiple sclerosis	3.51e-05	0.000266	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.5e-05	0.00578	CbGpPWpGaD
Perindopril—Nausea—Methotrexate—multiple sclerosis	3.33e-05	0.000252	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.25e-05	0.00536	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	3.22e-05	0.00531	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD28—multiple sclerosis	3.13e-05	0.00516	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	2.99e-05	0.00494	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—POMC—multiple sclerosis	2.99e-05	0.00493	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	2.97e-05	0.0049	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.9e-05	0.00479	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.9e-05	0.00479	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD40—multiple sclerosis	2.85e-05	0.00471	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	2.81e-05	0.00464	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.76e-05	0.00457	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—BCHE—multiple sclerosis	2.72e-05	0.00449	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	2.57e-05	0.00424	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.57e-05	0.00424	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	2.48e-05	0.00409	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.44e-05	0.00404	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	2.32e-05	0.00382	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.27e-05	0.00375	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD86—multiple sclerosis	2.23e-05	0.00368	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	2.19e-05	0.00361	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL10—multiple sclerosis	2.19e-05	0.00361	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL4—multiple sclerosis	2.13e-05	0.00351	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	2.08e-05	0.00344	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—SLC30A7—multiple sclerosis	2.04e-05	0.00338	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—FAS—multiple sclerosis	1.96e-05	0.00324	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	1.95e-05	0.00322	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	1.93e-05	0.00318	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SRM—multiple sclerosis	1.83e-05	0.00303	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.76e-05	0.00291	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.73e-05	0.00286	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	1.65e-05	0.00273	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.63e-05	0.00269	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.61e-05	0.00265	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	1.49e-05	0.00246	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.45e-05	0.00239	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.41e-05	0.00233	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—POMC—multiple sclerosis	1.41e-05	0.00232	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CCL2—multiple sclerosis	1.38e-05	0.00227	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.31e-05	0.00216	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP24A1—multiple sclerosis	1.29e-05	0.00213	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP27B1—multiple sclerosis	1.29e-05	0.00213	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.29e-05	0.00212	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GPC5—multiple sclerosis	1.18e-05	0.00195	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.15e-05	0.00189	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.14e-05	0.00189	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.13e-05	0.00187	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.1e-05	0.00181	CbGpPWpGaD
Perindopril—BCHE—Metabolism—RRM1—multiple sclerosis	9.79e-06	0.00162	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	9.67e-06	0.0016	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SRM—multiple sclerosis	8.95e-06	0.00148	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	8.91e-06	0.00147	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.8e-06	0.00145	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.68e-06	0.00143	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.52e-06	0.00141	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—TNF—multiple sclerosis	8.32e-06	0.00137	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.17e-06	0.00135	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.67e-06	0.00127	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.6e-06	0.00126	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—MAPK1—multiple sclerosis	6.53e-06	0.00108	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.53e-06	0.00108	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP27B1—multiple sclerosis	6.31e-06	0.00104	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP24A1—multiple sclerosis	6.31e-06	0.00104	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.95e-06	0.000983	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GPC5—multiple sclerosis	5.77e-06	0.000953	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—POMC—multiple sclerosis	5.64e-06	0.000932	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	5.52e-06	0.000912	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—RRM1—multiple sclerosis	4.78e-06	0.000789	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.41e-06	0.000728	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.4e-06	0.000726	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.31e-06	0.000712	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.11e-06	0.000678	CbGpPWpGaD
Perindopril—BCHE—Metabolism—APOE—multiple sclerosis	3.38e-06	0.000559	CbGpPWpGaD
Perindopril—BCHE—Metabolism—POMC—multiple sclerosis	2.91e-06	0.00048	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.76e-06	0.000456	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—BCHE—multiple sclerosis	2.74e-06	0.000453	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALB—multiple sclerosis	2.65e-06	0.000438	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—APOE—multiple sclerosis	1.65e-06	0.000273	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—POMC—multiple sclerosis	1.42e-06	0.000234	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALB—multiple sclerosis	1.29e-06	0.000214	CbGpPWpGaD
